Saturday 17 October 2026
Export ZCMD’s income statement to Excel — free account
Zhongchao Inc.
ZCMD Healthcare Health Information Services
Zhongchao Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, down 28.3% from fiscal 2024.
1.29
0.10
−7.19%
Follow ZCMD
Zhongchao Inc. (ZCMD) P/E ratio
Zhongchao Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 151,089× (July 2022) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 139,402× | 87.37% |
| FY2020 | 74,400× | 297,500.00% |
| FY2019 | 25.0× | 0.00% |
| FY2018 | 25.0× | 0.00% |
| FY2017 | 25.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2023 | 0.0× | — |
| Dec 2022 | 0.0× | — |
| Jun 2022 | 74,171× | 6.41% |
| Dec 2021 | 69,701× | 57.84% |
| 5 more quarters | Free account |
Against its own ten years
Low 0.0×
High 151,089×
Ten-year median
0.0×
Current reading's percentile
57
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ETAOF ETAO International Co., Ltd. compare | n/m |
| MGRX Mangoceuticals, Inc. compare | n/m |
| ACON Aclarion, Inc. compare | n/m |
| VSEED VSee Health, Inc. compare | n/m |
| BFRG Bullfrog AI Holdings Inc. compare | n/m |
| ZCMD Zhongchao Inc. | n/m |
| RNLXY Renalytix plc - Sponsored ADR compare | n/m |
| HLTHQ Cue Health Inc. compare | n/m |
| HCTI Healthcare Triangle, Inc. compare | 0.0× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)